1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Active Pharmaceutical Ingredients (API) Market in India 2015-2019

Active Pharmaceutical Ingredients (API) Market in India 2015-2019

  • January 2015
  • -
  • Infiniti Research Limited
  • -
  • 64 pages

Summary

Table of Contents

Search Inside

About Active Pharmaceutical Ingredients
Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.
TechNavio's analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019.

Covered in this Report
This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process and area of therapy.
In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, the API Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Vendors
• Aurobindo Pharma
• Cipla
• Dr. Reddy's Laboratories
Other Prominent Vendors

• Anuh Pharma
• Alembic Pharmaceuticals
• A. R. Life Sciences
• Atul Bioscience
• Biocon
• Cadila Pharmaceuticals
• Calyx Chemicals & Pharmaceuticals
• CIRON Drugs and Pharmaceuticals
• CTX Life Sciences
• Dishman Pharmaceuticals & Chemicals
• Elder Pharmaceuticals
• Emcure Pharmaceuticals
• FDC
• Glenmark Pharmaceuticals
• Hetero Drugs
• Hikal
• Ind-Swift Laboratories
• Ipca Laboratories
• J. B. Chemicals and Pharmaceuticals
• Laurus Labs
• Lupin
• Mangalam Drugs & Organics
• Mylan Laboratories
• Orchid Chemicals and Pharmaceuticals
• Ranbaxy Laboratories
• Sandoz
• Sequent Scientific
• Shasun Pharmaceuticals
• Sterling Biotech
• Sun Pharmaceutical Industries
• The Piramal Group
• Torrent Pharmaceuticals
• Unichem Laboratories
• Wockhardt



Market Driver
• Strong Preference for Generic Drugs
• For a full, detailed list, view our report

Market Challenge
• Regulatory Ban
• For a full, detailed list, view our report

Market Trend
• Emergence of Africa
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.